Agilent launches SARS-CoV-2 antibody immunoassay kit

LabPulse.com staff writers
Feb 17, 2021
2020 10 30 23 08 8077 Sars Co V 2 400

Agilent Technologies has launched a new immunoassay kit for the detection of SARS-CoV-2 antibodies. The kit represents Agilent's entry into the U.S. SARS-CoV-2 testing market, according to the firm.

The test is called Agilent Dako SARS-CoV-2 immunoglobulin G (IgG) Enzyme-Linked Immunosorbent Assay (ELISA), and it identifies IgG antibodies to SARS-CoV-2 in human serum or plasma.

The test has 98.9% sensitivity and 98.8% specificity, the company said.

Latest in Immunoassays
Blood Cells Vessel Social
University of Iowa pathologists suggest best-practice advisory for SRA testing
January 7, 2025
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Gavel Handcuffs Proxima Studio
Lucy Letby murder case flags immunoassays as unreliable for medical evidence
October 28, 2024
3 D Monkeypox Infecting Cell Social
WHO approves Abbott mpox test for emergency use
October 4, 2024
Related Stories
2022 02 10 03 12 6159 Computer Data 400
Microscopy & Imaging
Agilent highlights automation platforms at SLAS 2022
2019 12 12 00 55 0189 Breast Cancer3 400
Breast Cancer
Agilent receives FDA approval for breast cancer assay
2020 04 14 17 10 6379 Test Tubes Rd Lab 400
Esophageal Cancer
Agilent secures expanded CE Mark for cancer assay
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Immunoassays
University of Iowa pathologists suggest best-practice advisory for SRA testing
By Liz Carey
Utilization analysis shows confirmatory serotonin release assays may be overused.
January 7, 2025
Blood Cells Vessel Social
OraSure awarded BARDA contract for Marburg virus disease test
By LabPulse.com staff writers
OraSure Technologies was awarded federal funding for the development of a Marburg virus disease rapid antigen test.
December 2, 2024
Research Money Social
Lucy Letby murder case flags immunoassays as unreliable for medical evidence
By Liz Carey
At least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.
October 28, 2024
Gavel Handcuffs Proxima Studio
WHO approves Abbott mpox test for emergency use
By LabPulse.com staff writers
The World Health Organization (WHO) authorized Abbott Laboratories' mpox diagnostic test under its emergency use listing procedure, the first such approval by the agency in its effort to expand the diagnostic capacity of countries facing mpox outbreaks.
October 4, 2024
3 D Monkeypox Infecting Cell Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
Rapid blood test for heart attack holds promise for shorter ED stays
By LabPulse.com staff writers
A rapid blood test that can distinguish heart attack in people presenting at emergency departments (EDs) with chest pain has been developed by researchers.
September 5, 2024
Heart Ekg Social
New assay developed for persistent African HIV strains
By LabPulse.com staff writers
A multinational research team has developed a test to measure the persistence of HIV in people who have been infected by strains of the virus found predominantly in Africa, providing a necessary tool in the search for a cure for HIV.
July 9, 2024
Hiv Virions Cdc Social
CRISPR-based paper test could improve influenza testing access, outbreak surveillance
By LabPulse.com staff writers
Researchers from the Broad Institute of MIT, Harvard, and Princeton University have developed a low-cost paper strip test that uses CRISPR to distinguish between the two main types of seasonal influenza, A and B, as well as subtypes H1N1 and H3N2.
June 21, 2024
Influenza Virus Social
FDA grants 510(k) clearance to Genetic Signature for parasitic GI infection kit
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Genetic Signature's EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated molecular workflow.
June 7, 2024
Lab Petri Microbiology Social
Roche garners FDA EUA for 4-in-1 respiratory panel
By LabPulse.com staff writers
Roche has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Cobas Liat SARS-CoV-2, influenza A/B, and RSV nucleic acid test.
June 10, 2024
Fda Sign Dc Social
Diasorin receives FDA 510(k) clearance for fungal infection panel
By LabPulse.com staff writers
Diasorin has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Liaison Plex Yeast Blood Culture assay, the second molecular multiplexing panel developed for the firm's Liaison Plex system.
June 6, 2024
Fda Button Social
University of Florida researchers develop CRISPR-based assay for HPV detection
By LabPulse.com staff writers
Researchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.
May 7, 2024
Hpv Niaid Social
Page 1 of 62
Next Page